Metformin Therapy Center

Could metformin potentially be the first medication approved to PREVENT dementia?

How does Imeglimin perform in combination with metformin in patients with type 2 diabetes?

Evidence has shown diabetic treatment options to improve beta-cell function and/or insulin sensitivity, but do these effects persist upon treatment withdrawal?

Which baseline clinical characteristics of patients with newly diagnosed diabetes lead us to providing more personalized care?

Which groups get the most benefit in diabetes prevention from using metformin?

Another medication taken for type 2 diabetes may also help reverse a potentially life-threatening heart condition.

This is not the first study showing these negative effects of metformin.

Drug said to be possible fix for multiple primary pathophysiologic abnormalities.

Metformin may help lower the risk of cardiovascular events and death in patients with moderate to severe renal function.

We asked the DIC advisory board to comment on the use of metformin in patients who do not have diabetes:
Your patients may have asked about it or, if not yet, they most likely will. What is your comment on whether you recommend metformin for people who do not have diabetes? If you do not, how do you respond to patients who ask about it? If you do, what do you tell your patients? And what do you say to your patients when their other health care providers tell them this is a diabetes drug and they should only be taking it if they have diabetes?
Here's how they responded.